Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma
- PMID: 3684402
Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma
Abstract
Saliva stimulation is required for measurement of drugs in saliva. Chewing on a piece of paraffin, which is the method usually used for saliva stimulation, requires cooperation of the patient and, thus, is inapplicable in infants and young children. To assess the value of determining theophylline concentrations from noninvasively obtained saliva in this age group, we studied the theophylline plasma to saliva concentration ratio in citric acid-stimulated saliva. Theophylline concentration was measured in 137 simultaneously obtained paired specimens of plasma and saliva from 68 patients 2 1/2 months to 14 years of age treated with theophylline for asthma (dosage 20.8 +/- 5.2 mg/kg/d, mean +/- SD). Saliva secretion was stimulated by placing citric acid crystals on the tongue. A strong and highly significant correlation was observed between both determinations (r = .96; P less than .01). The plasma to saliva ratio was 1.78 +/- 0.22 (mean +/- SD), with theophylline concentrations between 3.1 and 32.1 micrograms/mL of plasma. The ratio of estimated to actual plasma theophylline concentrations was 1.02 +/- 0.12 (mean +/- SD). Interindividual coefficient of variation of plasma to saliva theophylline concentrations ratios was 12.4%; mean intraindividual coefficient of variation was 5.3%. The use of citric acid for saliva stimulation is easily applicable to infants and young children. Compared with blood drawing, stimulation of saliva secretion by citric acid is painless and noninvasive, is more readily accepted to patients, is at least as clinically relevant for theophylline determination, and allows frequent measurements of drug levels for individualization of the dosage with samples taken at home.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.J Allergy Clin Immunol. 1990 Aug;86(2):238-43. J Allergy Clin Immunol. 1990. PMID: 2384651
-
Salivary theophylline monitoring in asthmatic children.Pol J Pharmacol Pharm. 1987 Mar-Apr;39(2):173-6. Pol J Pharmacol Pharm. 1987. PMID: 3432165
-
Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.Pharmatherapeutica. 1985;4(5):285-7. Pharmatherapeutica. 1985. PMID: 4070321
-
[Peculiarities of theophylline therapy in childhood].Z Erkr Atmungsorgane. 1988;170(2):100-7. Z Erkr Atmungsorgane. 1988. PMID: 3041688 Review. German.
-
Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring.Dev Pharmacol Ther. 1992;19(4):161-77. doi: 10.1159/000457481. Dev Pharmacol Ther. 1992. PMID: 1343619 Review.
Cited by
-
Digoxin concentration in saliva and plasma in infants, children, and adolescents with heart disease.Curr Ther Res Clin Exp. 2003 Nov;64(9):743-9. doi: 10.1016/j.curtheres.2003.09.015. Curr Ther Res Clin Exp. 2003. PMID: 24944422 Free PMC article.
-
Use of saliva specimens for monitoring indinavir therapy in human immunodeficiency virus-infected patients.Antimicrob Agents Chemother. 2000 Sep;44(9):2572-4. doi: 10.1128/AAC.44.9.2572-2574.2000. Antimicrob Agents Chemother. 2000. PMID: 10952622 Free PMC article. Clinical Trial.